Form 4 Filing for Wolf Lisa G

Lisa G. Wolf, COO & CFO of Valion Bio, Inc., reported transactions on September 18, 2026. Wolf acquired 4 shares of Common Stock with a transaction code "M" and disposed of 4 Restricted Stock Units, convertible into Common Stock, also with a transaction code "M". Additionally, Wolf forfeited 2 shares of Common Stock to cover tax withholdings, indicated by transaction code "F", at a price of $2.12 per share. These transactions resulted in post-transaction holdings of 29 shares of Common Stock and 19 Restricted Stock Units. The reported shares were adjusted to reflect a 1-for-25 reverse stock split effective August 31, 2026. The Restricted Stock Units vest in installments, with 50% vesting on the one-year anniversary of the grant date and the remainder vesting quarterly over the subsequent two years.